Episode Details

Back to Episodes
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals

Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals

Published 2 months, 3 weeks ago
Description
FDA approves three new therapies spanning autoimmune disease, HIV, and cardiovascular risk, DualityBio and Teva strike major biopharma deals, and Israel Ortiz makes the case for preventive maintenance in manufacturing.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us